Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of acute and severe thrombocytopenia due to readministration of rifampicin.
Mori M, Izawa K, Fujikawa T, Uenami T, Sugano T, Kagami S, Namba Y, Yano Y, Yoneda T, Kitada S, Kimura H, Yamaguchi T, Yokota S, Maekura R. Mori M, et al. Among authors: yano y. J Infect Chemother. 2011 Apr;17(2):288-90. doi: 10.1007/s10156-010-0117-x. Epub 2010 Sep 9. J Infect Chemother. 2011. PMID: 20827562
Inflammatory pseudotumor of the lung with rapid growth.
Yano Y, Mori M, Kagami S, Fushitani K, Sugano T, Namba Y, Yoneda T, Yokota S, Maeda H, Ueda K. Yano Y, et al. Intern Med. 2009;48(15):1279-82. doi: 10.2169/internalmedicine.48.2201. Epub 2009 Aug 3. Intern Med. 2009. PMID: 19652430 Free article. Review.
Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens.
Ogata A, Mori M, Hashimoto S, Yano Y, Fujikawa T, Kawai M, Kuwahara Y, Hirano T, Arimitsu J, Hagihara K, Shima Y, Narazaki M, Yokota S, Kishimoto T, Kawase I, Tanaka T. Ogata A, et al. Among authors: yano y. Mod Rheumatol. 2010 Apr;20(2):130-3. doi: 10.1007/s10165-009-0243-4. Epub 2009 Nov 7. Mod Rheumatol. 2010. PMID: 19898919
CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy.
Kohmo S, Kijima T, Mori M, Minami T, Namba Y, Yano Y, Yoneda T, Takeda Y, Kitada S, Yamaguchi T, Tachibana I, Yokota S. Kohmo S, et al. Among authors: yano y. Tuberculosis (Edinb). 2012 May;92(3):248-52. doi: 10.1016/j.tube.2012.01.001. Epub 2012 Jan 30. Tuberculosis (Edinb). 2012. PMID: 22297026
Laryngeal tuberculosis: a diagnosis that should be remembered.
Kitahara K, Yano Y, Mori M, Yokota S. Kitahara K, et al. Among authors: yano y. Intern Med. 2012;51(19):2841-2. doi: 10.2169/internalmedicine.51.8503. Epub 2012 Oct 1. Intern Med. 2012. PMID: 23037489 Free article. No abstract available.
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
Azuma J, Ohno M, Kubota R, Yokota S, Nagai T, Tsuyuguchi K, Okuda Y, Takashima T, Kamimura S, Fujio Y, Kawase I; Pharmacogenetics-based tuberculosis therapy research group. Azuma J, et al. Eur J Clin Pharmacol. 2013 May;69(5):1091-101. doi: 10.1007/s00228-012-1429-9. Epub 2012 Nov 14. Eur J Clin Pharmacol. 2013. PMID: 23150149 Free PMC article. Clinical Trial.
1,754 results